An interventional study of Mailed Urinalysis Smartphone Kit in Albuminuria, Chronic Kidney Diseases and Cardiovascular Diseases, sponsored by Geisinger Clinic. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-07-24.
Sponsored by Geisinger Clinic · Not applicable, Interventional, and Screening
Among 50 studies in Albuminuria with a site in United States — 9 open to participants now, 11 under way, none of them phase 3. Albuminuria · United States.
Among the 50 studies in Albuminuria with a site in United States, this one is the 5th largest by enrollment of the 42 interventional ones that give a count, is one of 2 that started in 2018, is one of 17 with no phase, and was the 35th registered.
142 studies on the registry are indexed under Albuminuria; 24 are open to participants now.
Browse Albuminuria studies →9 of the 50 studies in Albuminuria with a site in United States are open now. Recruiting first, the newest first:
Geisinger Clinic · Sites in United States
Ages 18+
University of Illinois at Chicago · Sites in United States
Ages 18–60
University of North Carolina, Chapel Hill · Sites in United States
Ages 18+
University of Colorado, Denver · Sites in United States
Ages 18–80
University of Tennessee · Sites in United States
Ages 18–65
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 13 Albuminuria studies recruiting now, 4 (31%) set no upper age limit and 5 (38%) stop at 75 or younger; 3 take children under 18; 2 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
50 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 17 · Phase 3 4 · Phase 4 6
First in 2001; this study’s year is marked. 2 started in 2018.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 999 is above the median of 69 across 115 interventional studies indexed under Albuminuria.
Median enrollment 60 across the 42 interventional studies, 403 across the 8 observational. Of the 38 that completed or were terminated, 20 (53%) have results posted.
This tab as a report to print or save as PDF → With an account.
15 of 50 have an industry lead sponsor. The 10 most frequent:
Geisinger Clinic is the lead sponsor of 127 studies on the registry; 17 are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 7 (78%) have results posted.
Geisinger Clinic has 5 studies filed under Albuminuria — fewer than ten, so there is no comparison to draw.
3 of the studies in Albuminuria with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04752293Wake Forest University Health SciencesPediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE) | 2026-12 |
| NCT05498116University of Colorado, DenverEffect of Montelukast on Kidney and Vascular Function in Type 1 Diabetes | 2027-02 |
| NCT06059664University of North Carolina, Chapel HillThe EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study | 2027-03-31 |
Add all 3 to your calendar (.ics) → With an account.
Among the 50 studies in Albuminuria with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study will test the effectiveness of mailed, smartphone urinalysis kits to improve albuminuria screening compliance and detection of albuminuria.
This proposal will examine the effect of mailed, smartphone urinalysis kits to improve albuminuria screening compliance and detection of albuminuria. The investigators will randomize 1,000 non-diabetic MyGeisinger portal users with hypertension and last clinic blood pressure >= 130/80 mmHg who have not received albuminuria screening to either: 1) control - usual care or 2) intervention - mailed urinalysis smartphone kit. All patients will first receive a reminder letter to have albuminuria screening completed at their clinic in coordination with the Geisinger Care Gap Team. Patients randomized to the intervention arm who do not complete this initial screening test will then be offered a mailed, smartphone urinalysis testing kit. Patients with 1+ or greater detected urine protein will be recommended to have urine albumin/creatinine ratio (ACR) testing to confirm albuminuria. Patients with ACR >= 30 mg/g will be referred to pharmacists for optimal treatment of albuminuria (ACE or ARB, statin, BP goal \<130/90 mmHg).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².
Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.
GFR and eGFR (kidney filtering)
GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².
Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
This arm will receive usual care.
This arm will receive a mailed urinalysis smartphone kit if they do not complete albuminuria screening after the initial reminder to do so.
Other: Mailed Urinalysis Smartphone Kit
Patients who fail to complete albuminuria screening after the initial reminder to do so, will be contacted by phone and offered a mailed smartphone urinalysis kit. Agreeable patients will then receive the mailed kit and instructions to use their smartphone camera to analyze a urine dipstick.
Completion of albuminuria screening
Includes completion of mailed smartphone urinalysis and clinical labs (urinalysis, albumin/creatinine ratio, or protein/creatinine ratio)
Time frame: Baseline to 3 months of enrollment date
Total number of detected albuminuria cases
confirmed by urine albumin/creatinine ratio \>= 30 mg/g
Time frame: Baseline to 3 months of enrollment date
Plan to share: Undecided — May be available upon request
Ran from Mar 2018 to primary completion in Jun 2018, 3 months.
Of 22 interventional studies with no phase under Albuminuria, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 21 and three quarters within 48. This study's 3 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.